Skip to main content
The Patent Truth About Health, Innovation and Access
Heer Pardesi, who is 42 years old, holds her antiretroviral drugs for HIV. (Jonas Gratzer/LightRocket via Getty Images)

The Patent Truth About Health, Innovation and Access

Carol Adelman

View PDF

This report reviews and analyzes the following premises of the U.N.‘s High Level Panel on Access to Medicines, which are:

  1. Millions of poor people in low- and middle-income countries have been denied access to antiretroviral drugs and other medicines;
  2. Patents are the main cause of higher costs of medicines for poor people in low- and middle-income countries;
  3. The intellectual property system, including patents and voluntary licenses, limits research and disadvantages local producers in low- and middle- income countries.

These basic assumptions, drawing from the earlier Global Commission on HIV and the Law and the new High Level Panel on Access to Medicines, however, are not supported by global health research.

View PDF

Related Articles

What Happens When 'Black Swans' Have Help: China's Failure to Act

Seth Cropsey

The U.S. stock market finished March with its largest drop since 2008. The S&P 500 fell by slightly under one-fifth; the Dow Jones industrials, by alm...

Continue Reading

America Needs A Back-To-Work Czar

Arthur Herman

America is finally using the World War II model for combating the coronavirus the right way, as "my last column()":https://www.forbes.com/sites/arthur...

Continue Reading

The Coronavirus Threat South of the Border

Walter Russell Mead

The Covid-19 pandemic has yet to strike Latin America and the Caribbean at full force, but the region’s fragile societies are already groaning under...

Continue Reading